(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYNAVCARE PATIENT SUPPORT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYNAVCARE PATIENT SUPPORT

ST13

US500000097936772

Class

35, 36, 44, 45

Filing

97936772

Registration

7819913

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

06/03/2025

Trademark type

Word

Nice classes

35, 36, 44, 45

Filing date

05/15/2023

Registration date

06/03/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2025

Last transaction

06/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/31/2023

First use in commerce

05/31/2023

Drawing code

4

Owner type

99

Owner location

Valby, DK

Examiner

GULIANO, ROBERT N

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Genmab A/S

Representatives

Max Vern Amster, Rothstein & Ebenstein LLP

Technical classification

Nice Classes

Class 35Class 36Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Class 36

Financial administration of patient reimbursement and patient financial assistance programsnamely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable servicesproviding financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance planspatient financial assistancepatient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Class 44

Medical assistancenamely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancerautoimmune diseasesinflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care servicesnamely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical servicesprovision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Class 45

Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatmentsemotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expensescompanionshiphelp with medical formsemotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Publications

History of USPTO decisions and trademark events.

45 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/03/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

06/03/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/09/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/09/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/28/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/28/2025

ALIE

ASSIGNED TO LIE

04/25/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/08/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/13/2025

GNRT

NON-FINAL ACTION E-MAILED

02/13/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

02/13/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/23/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/23/2025

IUAF

USE AMENDMENT FILED

11/07/2024

EISU

TEAS STATEMENT OF USE RECEIVED

11/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/19/2024

PUBO

PUBLISHED FOR OPPOSITION

03/19/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/28/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/28/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/31/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/30/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/30/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/23/2024

GNRT

NON-FINAL ACTION E-MAILED

01/23/2024

CNRT

NON-FINAL ACTION WRITTEN

01/23/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/18/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/17/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/15/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/15/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/15/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/15/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/15/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/17/2023

GNRT

NON-FINAL ACTION E-MAILED

10/17/2023

CNRT

NON-FINAL ACTION WRITTEN

10/17/2023

DOCK

ASSIGNED TO EXAMINER

10/11/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/13/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/13/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2023

NWAP

NEW APPLICATION ENTERED

05/18/2023

Continuous trademark protection

Get notified about every new filing that threatens MYNAVCARE PATIENT SUPPORT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.